首頁 › 肝癌（肝細胞癌） › 俄勒岡州 › Portland
Portland, OR 的 肝癌（肝細胞癌） 臨床試驗
11 項針對 肝癌（肝細胞癌） 的研究正在 Portland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #51, Portland
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
招募中1/2 期
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
招募中1/2 期
- Oregon Health and Sciences University, Portland
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
招募中1/2 期
- Oregon Health and Science University, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Oregon Health and Science University, Portland
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 距離 12 英里
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- Providence Cancer Institute, Portland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA Portland Health Care System, Portland, OR, Portland
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
招募中4 期
- OHSU Knight Cancer Institute, Portland
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
招募中2 期
- USA15-0, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Portland
其他城市的 肝癌（肝細胞癌） 試驗
- Houston, TX31 項研究
- New York City, NY24 項研究
- Dallas, TX19 項研究
- Los Angeles, CA19 項研究
- Boston, MA18 項研究
- Cleveland, OH18 項研究
- Chicago, IL16 項研究
- Philadelphia, PA16 項研究
- Pittsburgh, PA15 項研究
- San Francisco, CA14 項研究
- Orange, CA14 項研究
- Jacksonville, FL14 項研究
Portland 的其他研究
- 非小細胞肺癌46 項研究
- 癌症（所有類型）34 項研究
- 乳癌33 項研究
- 前列腺癌33 項研究
- 轉移性癌症29 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 肺癌26 項研究
- 急性髓系白血病25 項研究
- 子宮內膜癌24 項研究
- 頭頸部鱗狀細胞癌19 項研究
- 胰臟癌19 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。